The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
VANGUARD INDEX FDS TOTAL STK MKT 922908769 164,431 2,917,000 SH   SOLE   2,917,000 0 0
VANGUARD INTL EQUITY INDEX F FTSE EUROPE ETF 922042874 65,836 1,358,000 SH   SOLE   1,358,000 0 0
BIOMIMETIC THERAPEUTICS INC COM 09064X101 44,380 3,720,065 SH   SOLE   3,720,065 0 0
ISHARES MSCI JAPAN ETF 464286848 6,818 700,000 SH   SOLE   700,000 0 0